224 related articles for article (PubMed ID: 26585689)
21. Soluble MMP-14 produced by bone marrow-derived stromal cells sheds epithelial endoglin modulating the migratory properties of human breast cancer cells.
Tobar N; Avalos MC; Méndez N; Smith PC; Bernabeu C; Quintanilla M; Martínez J
Carcinogenesis; 2014 Aug; 35(8):1770-9. PubMed ID: 24618373
[TBL] [Abstract][Full Text] [Related]
22. Role of high-molecular weight tropomyosins in TGF-beta-mediated control of cell motility.
Zheng Q; Safina A; Bakin AV
Int J Cancer; 2008 Jan; 122(1):78-90. PubMed ID: 17721995
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of TGF-β1 expression in human umbilical cord mesenchymal stem cells reverts their exosome-mediated EMT promoting effect on lung cancer cells.
Zhao X; Wu X; Qian M; Song Y; Wu D; Zhang W
Cancer Lett; 2018 Aug; 428():34-44. PubMed ID: 29702191
[TBL] [Abstract][Full Text] [Related]
24. Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands.
SenGupta S; Hein LE; Xu Y; Zhang J; Konwerski JR; Li Y; Johnson C; Cai D; Smith JL; Parent CA
Front Immunol; 2021; 12():659996. PubMed ID: 33912188
[TBL] [Abstract][Full Text] [Related]
25. Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding.
De Wever O; Westbroek W; Verloes A; Bloemen N; Bracke M; Gespach C; Bruyneel E; Mareel M
J Cell Sci; 2004 Sep; 117(Pt 20):4691-703. PubMed ID: 15331629
[TBL] [Abstract][Full Text] [Related]
26. Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer.
Stuelten CH; Busch JI; Tang B; Flanders KC; Oshima A; Sutton E; Karpova TS; Roberts AB; Wakefield LM; Niederhuber JE
PLoS One; 2010 Mar; 5(3):e9832. PubMed ID: 20352126
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Ueda Y; Wang S; Dumont N; Yi JY; Koh Y; Arteaga CL
J Biol Chem; 2004 Jun; 279(23):24505-13. PubMed ID: 15044465
[TBL] [Abstract][Full Text] [Related]
28. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
29. Activation of fibroblasts by nicotine promotes the epithelial-mesenchymal transition and motility of breast cancer cells.
Chen PC; Lee WY; Ling HH; Cheng CH; Chen KC; Lin CW
J Cell Physiol; 2018 Jun; 233(6):4972-4980. PubMed ID: 29215705
[TBL] [Abstract][Full Text] [Related]
30. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
Wang XG; Meng Q; Qi FM; Yang QF
Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells promote cell invasion and migration and autophagy-induced epithelial-mesenchymal transition in A549 lung adenocarcinoma cells.
Luo D; Hu S; Tang C; Liu G
Cell Biochem Funct; 2018 Mar; 36(2):88-94. PubMed ID: 29372557
[TBL] [Abstract][Full Text] [Related]
32. The effect of mesenchymal stem cell-conditioned medium on proliferation and apoptosis of breast cancer cell line.
Farahmand L; Esmaeili R; Eini L; Majidzadeh-A K
J Cancer Res Ther; 2018; 14(2):341-344. PubMed ID: 29516916
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta.
Patel SA; Meyer JR; Greco SJ; Corcoran KE; Bryan M; Rameshwar P
J Immunol; 2010 May; 184(10):5885-94. PubMed ID: 20382885
[TBL] [Abstract][Full Text] [Related]
34. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
[TBL] [Abstract][Full Text] [Related]
35. Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma.
Hong D; Liu T; Huang W; Liao Y; Wang L; Zhang Z; Chen H; Zhang X; Xiang Q
Cell Physiol Biochem; 2018; 47(5):1785-1799. PubMed ID: 29953975
[TBL] [Abstract][Full Text] [Related]
36. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells.
De Luca A; Gallo M; Aldinucci D; Ribatti D; Lamura L; D'Alessio A; De Filippi R; Pinto A; Normanno N
J Cell Physiol; 2011 Aug; 226(8):2131-8. PubMed ID: 21520065
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stem cells co-cultured with colorectal cancer cells showed increased invasive and proliferative abilities due to its altered p53/TGF-β1 levels.
Oh IR; Raymundo B; Kim M; Kim CW
Biosci Biotechnol Biochem; 2020 Feb; 84(2):256-267. PubMed ID: 31601153
[TBL] [Abstract][Full Text] [Related]
38. CD9 Upregulation-Decreased CCL21 Secretion in Mesenchymal Stem Cells Reduces Cancer Cell Migration.
Hsieh CC; Hsu SC; Yao M; Huang DM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572290
[TBL] [Abstract][Full Text] [Related]
39. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta receptor kinase inhibitor LY2109761 reverses the anti-apoptotic effects of TGF-beta1 in myelo-monocytic leukaemic cells co-cultured with stromal cells.
Xu Y; Tabe Y; Jin L; Watt J; McQueen T; Ohsaka A; Andreeff M; Konopleva M
Br J Haematol; 2008 Jun; 142(2):192-201. PubMed ID: 18492113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
